por Sdli Scouter | Feb 16, 2021 | Sector and Trends
Summary: «With a Takeda collaboration already in its pocket, Ensoma announced a $70 million Series A round to help develop its platform of engineered gene therapy vectors for off-the-shelf in vivo therapeutics, starting in rare diseases.» «Ensoma is...
por Sdli Scouter | Feb 16, 2021 | Sector and Trends, Startups
Summary: «Carrum Health, an innovative surgery benefit offered to self-insured employers, announced that it is expanding the availability of complex cardiac care for its members with Cleveland Clinic. By joining forces with the leading heart and vascular program...
por Sdli Scouter | Feb 16, 2021 | Sector and Trends, Startups
Summary: «Adeno-associated viruses have become popular vectors for the delivery of gene therapies. But, despite their relatively safe profile, they can trigger some unwanted immune responses, which may reduce treatment efficacy or, worse, cause serious side...
por Sdli Scouter | Feb 16, 2021 | Sector and Trends
Summary: «It may lift personalized treatment, fill gaps in access to care, cut red tape but risks abound» «Third in a series that taps the expertise of the Harvard community to examine the promise and potential pitfalls of the coming age of artificial intelligence and...
por Sdli Scouter | Feb 16, 2021 | Diagnostic Tools, Digital Patient, Prevention
Summary: «Diet, exercise, and other lifestyle factors are known to affect your risk of heart disease.The major risk factors for heart disease, as well as the condition itself, are all closely linked to the risk of developing atrial fibrillation. Can a heart-healthy...
